New compounds from fungi show promise in treating colorectal cancer

Novel chemical compounds from a fungus could provide new perspectives for treating colorectal cancer, one of the most common and deadliest cancers worldwide.

Viking’s $350M offering; Baker Brothers leads another PIPE

Plus, news about Applied Therapeutics, Beam Therapeutics, Janux Therapeutics and more: Viking Therapeutics sells off $350M of stock following positive obesity drug data: On the

February 29, 2024

Vaccines and Long COVID: What Do We Know?

Vaccines are now a key tool in preventing acute, severe COVID-19. But less is known about their effect on long COVID. Does vaccination against SARS-CoV-2

October 5, 2024

Beyond approval: Patients pursue alternate paths to get rare disease treatments –

Share this article In many cases rare disease drug approvals do not significantly improve access to patients, leading patients to seek alternative treatment options. Credit:

February 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.